Page last updated: 2024-10-30

ketotifen and Abdominal Pain

ketotifen has been researched along with Abdominal Pain in 4 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Abdominal Pain: Sensation of discomfort, distress, or agony in the abdominal region.

Research Excerpts

ExcerptRelevanceReference
"Eosinophilic gastroenteritis is a rare condition of unknown etiology characterized by peripheral eosinophilia, eosinophilic infiltration of the gastrointestinal tract, and gastrointestinal symptomatology."1.29Eosinophilic gastroenteritis. ( Hodges, WG; Huggins, TL; Lee, EL; Lee, M, 1996)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hui, CK1
Hui, NK1
van Diest, SA1
Stanisor, OI1
de Jonge, WJ1
Boeckxstaens, GE1
van den Wijngaard, RM1
Sebastián Domingo, JJ1
Lee, M1
Hodges, WG1
Huggins, TL1
Lee, EL1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Pilot Study of Omalizumab in Eosinophilic Gastroenteritis[NCT00084097]Phase 230 participants Interventional2004-06-02Completed
Pilot Study of Omalizumab (Xolair) in Hyper IgE (Job's) Syndrome[NCT00260702]Phase 11 participants (Actual)Interventional2005-11-24Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

4 other studies available for ketotifen and Abdominal Pain

ArticleYear
A Prospective Study on the Prevalence, Extent of Disease and Outcome of Eosinophilic Gastroenteritis in Patients Presenting with Lower Abdominal Symptoms.
    Gut and liver, 2018, May-15, Volume: 12, Issue:3

    Topics: Abdominal Pain; Acetates; Adolescent; Adult; Anti-Inflammatory Agents; Colon, Descending; Colon, Sig

2018
Visceral hypersensitivity in IBS: from bench to bedside.
    Journal of pediatric gastroenterology and nutrition, 2011, Volume: 53 Suppl 2

    Topics: Abdominal Pain; Animals; Histamine H1 Antagonists; Humans; Hypersensitivity; Irritable Bowel Syndrom

2011
[The irritable bowel syndrome, should not be considered a functional disorder?].
    Medicina clinica, 2013, May-04, Volume: 140, Issue:9

    Topics: Abdominal Pain; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Translocation; Causality

2013
Eosinophilic gastroenteritis.
    Southern medical journal, 1996, Volume: 89, Issue:2

    Topics: Abdominal Pain; Adult; Aged; Anemia; Anti-Allergic Agents; Cromolyn Sodium; Diarrhea; Eosinophilia;

1996
Eosinophilic gastroenteritis.
    Southern medical journal, 1996, Volume: 89, Issue:2

    Topics: Abdominal Pain; Adult; Aged; Anemia; Anti-Allergic Agents; Cromolyn Sodium; Diarrhea; Eosinophilia;

1996
Eosinophilic gastroenteritis.
    Southern medical journal, 1996, Volume: 89, Issue:2

    Topics: Abdominal Pain; Adult; Aged; Anemia; Anti-Allergic Agents; Cromolyn Sodium; Diarrhea; Eosinophilia;

1996
Eosinophilic gastroenteritis.
    Southern medical journal, 1996, Volume: 89, Issue:2

    Topics: Abdominal Pain; Adult; Aged; Anemia; Anti-Allergic Agents; Cromolyn Sodium; Diarrhea; Eosinophilia;

1996